Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of pharmaceuticals and agrochemicals. Its boronic acid group enables efficient carbon-carbon bond formation, particularly in the development of bioactive molecules containing trifluoromethylpyridine moieties. The electron-withdrawing trifluoromethyl group enhances metabolic stability and lipophilicity, making this compound valuable in medicinal chemistry for designing drug candidates with improved pharmacokinetic properties. It is also employed in the preparation of functional materials and ligands for catalysis.